About Vectura

Inhalation is our focus. With more than 20 years’ experience, we can help you succeed in bringing inhaled medicines to market.

Track Record

Our partners have succeeded in bringing DPI, pMDI and nebuliser medicines to market with the help of our specialist capabilities.

Our combination of formulation science, device technology and inhaled development expertise has contributed to the success of 11 inhaled medicines, launched by our partners and licensees.

Since launch, they have generated $10 billion in sales and in 2018 these products were used by 9 million patients worldwide.

More information

20+

years' experience in inhaled product development

11

inhaled on-market medicines, launched by our partners and licensees

$10bn

total sales of products using our formulation and device technology since launch

9m

patients using products utilising Vectura’s intellectual property in 2018